Global Neurovascular Devices Market by Disease Pathology, Devices, End-User - Forecast 2024-2030- Product Image

Sale

Global Neurovascular Devices Market by Disease Pathology, Devices, End-User - Forecast 2024-2030

Report
197 Pages
March 2024
Region: Global
360iResearch™
ID: 5454977

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Neurovascular Devices Market size was estimated at USD 3.21 billion in 2023, USD 3.44 billion in 2024, and is expected to grow at a CAGR of 7.34% to reach USD 5.28 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics Inc., Artio Medical, Inc., B. Braun Melsungen AG, BALT Group, Boston Scientific Corporation, Cerus Endovascular Inc., CONMED Corporation, Cook Medical Group, Endologix Inc., Evasc Medical Systems Corp., Integra Lifesciences Corporation, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medical Murray, Medtronic PLC, Microvention Inc., Penumbra, Inc., Phenox GmbH by Wallaby Medical, Rapid Medical Ltd., Scientia Vascular, Inc., Secant Group, LLC, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zeus Company Inc.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Pathology
- Aneurysm
- Arteriovenous Malformation & Fistulas
- Ischemic Stroke
- Stenosis
Devices
- Cerebral Angioplasty & Stenting Systems
  - Embolic Coils
  - Flow Diverters
  - Liquid Embolic Agents
- Cerebral Embolization & Aneurysm Coiling Devices
  - Carotid Artery Stents
  - Embolic Protection Systems
- Neurothrombectomy Devices
  - Clot Retrieval Devices
  - Suction Devices
  - Vascular Snares
- Support Devices
  - Micro Catheters
  - Micro Guidewires
End-User
- Ambulatory Surgical Centers
- Hospitals
- Specialized Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Neurovascular Devices Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Devices Market?
What are the technology trends and regulatory frameworks in the Neurovascular Devices Market?
What is the market share of the leading vendors in the Neurovascular Devices Market?
Which modes and strategic moves are suitable for entering the Neurovascular Devices Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Neurovascular Devices Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
5.1.2. Restraints
5.1.2.1. High cost associated with the neurovascular interventions and devices
5.1.3. Opportunities
5.1.3.1. Emerging research activities and technological advancements in the field of neurovascular therapies
5.1.3.2. Ongoing product development and approvals of neurovascular devices
5.1.4. Challenges
5.1.4.1. Limited availability of neurosurgeons across the globe
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Neurovascular Devices Market, by Disease Pathology

6.1. Introduction
6.2. Aneurysm
6.3. Arteriovenous Malformation & Fistulas
6.4. Ischemic Stroke
6.5. Stenosis

7. Neurovascular Devices Market, by Devices

7.1. Introduction
7.2. Cerebral Angioplasty & Stenting Systems
7.3.1. Embolic Coils
7.3.2. Flow Diverters
7.3.3. Liquid Embolic Agents
7.3. Cerebral Embolization & Aneurysm Coiling Devices
7.4.1. Carotid Artery Stents
7.4.2. Embolic Protection Systems
7.4. Neurothrombectomy Devices
7.5.1. Clot Retrieval Devices
7.5.2. Suction Devices
7.5.3. Vascular Snares
7.5. Support Devices
7.6.1. Micro Catheters
7.6.2. Micro Guidewires

8. Neurovascular Devices Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialized Clinics

9. Americas Neurovascular Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Neurovascular Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Acandis GmbH
13.1.2. AngioDynamics Inc.
13.1.3. Artio Medical, Inc.
13.1.4. B. Braun Melsungen AG
13.1.5. BALT Group
13.1.6. Boston Scientific Corporation
13.1.7. Cerus Endovascular Inc.
13.1.8. CONMED Corporation
13.1.9. Cook Medical Group
13.1.10. Endologix Inc.
13.1.11. Evasc Medical Systems Corp.
13.1.12. Integra Lifesciences Corporation
13.1.13. iVascular S.L.U.
13.1.14. Johnson & Johnson Services, Inc.
13.1.15. Koninklijke Philips N.V.
13.1.16. Lepu Medical Technology(Beijing)Co.,Ltd.
13.1.17. Medical Murray
13.1.18. Medtronic PLC
13.1.19. Microvention Inc.
13.1.20. Penumbra, Inc.
13.1.21. Phenox GmbH by Wallaby Medical
13.1.22. Rapid Medical Ltd.
13.1.23. Scientia Vascular, Inc.
13.1.24. Secant Group, LLC
13.1.25. Stryker Corporation
13.1.26. Terumo Corporation
13.1.27. W. L. Gore & Associates, Inc.
13.1.28. Zeus Company Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROVASCULAR DEVICES MARKET DYNAMICS
FIGURE 7. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
FIGURE 8. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2030 (%)
FIGURE 10. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 6. NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 11. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 18. NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 22. NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 27. NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 57. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 93. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 94. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 96. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 97. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 98. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 100. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 101. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 103. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 104. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 105. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 114. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 115. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 119. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 156. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 157. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 160. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 161. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 179. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 182. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 183. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 185. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 186. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 187. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 189. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 190. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 192. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 193. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 199. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 200. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 203. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 207. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 210. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 211. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 220. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 221. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 223. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 224. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 225. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 242. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 248. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 249. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 251. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 252. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 253. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 255. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 256. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 258. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 259. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 260. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 283. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 284. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 285. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 304. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 305. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 306. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 308. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABL

Companies Mentioned

Acandis GmbH
AngioDynamics Inc.
Artio Medical, Inc.
B. Braun Melsungen AG
BALT Group
Boston Scientific Corporation
Cerus Endovascular Inc.
CONMED Corporation
Cook Medical Group
Endologix Inc.
Evasc Medical Systems Corp.
Integra Lifesciences Corporation
iVascular S.L.U.
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
Lepu Medical Technology(Beijing)Co.,Ltd.
Medical Murray
Medtronic PLC
Microvention Inc.
Penumbra, Inc.
Phenox GmbH by Wallaby Medical
Rapid Medical Ltd.
Scientia Vascular, Inc.
Secant Group, LLC
Stryker Corporation
Terumo Corporation
W. L. Gore & Associates, Inc.
Zeus Company Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.44 Billion
Forecasted Market Value ( USD ) by 2030	$ 5.28 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	28

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

Global Neurovascular Devices Market (2023-2028) by Products, Disease Pathology, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

Neurovascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Neurovascular Devices Market Analysis & Forecast to 2024-2034

Global Neurovascular Devices Market Report and Forecast 2023-2031